KIAA0528-BCAT1 Fusion FISH Probe
The KIAA0528-BCAT1 Fusion FISH Probe is used to confirm a fusion of the KIAA0528 and BCAT1 genes. The fusion of the KIAA0528 and BCAT1 genes has been associated with Pancreatic Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| KIAA0528-BCAT1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| KIAA0528-BCAT1-20-AQAQ | 20 (40 μL) | 200 μL |
|
BCAT1 Gene Summary
This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. As there is also a gene encoding a mitochondrial form of this enzyme, mutations in either gene may contribute to these disorders. Alternatively spliced transcript variants have been described. [provided by RefSeq, May 2010]
Gene Name: Branched Chain Amino Acid Transaminase 1
Chromosome: CHR12: 24962957 -25102393
Locus: 12p12.1
Gene Diseases
The KIAA0528 BCAT1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Pancreatic Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|